Login
Password
Remember Me
National Initiative for RNA Biology and its Applications launched in Singapore RNA biology and its applications has been identified as a...
Merck KGaA to triple its ADC manufacturing capacity in St. Louis The German science and technology group Merck KGaA has...
Vivet Therapeutics receives €4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis Funding from French...
More articles from NEWS
True cost of sickle cell disease: $1.5 billion in lost productivity per year Sickle cell disease causes $1.5 billion in lost...
Record financing for the regenerative medicine sector through Q3 2020 The regenerative medicine sector attracted $15.9 billion in financing through just...
How to increase the number of European-based ATMP clinical trials? The latest report published by the Alliance for Regenerative Medicine (ARM),...
More articles from ANALYSES
Study suggests new molecular strategy for treating fragile X syndrome Building on more than two decades of research, a study by...
Novel gene therapy trial for sickle cell disease launches in the US The study uses CRISPR to correct sickle cell mutation...
Preclinical data for AAV-FGF21 gene therapy shows durable reversal of liver fibrosis UAB researchers have cured liver disease MASH in mouse...
More articles from SCIENTIFIC NEWS